# Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine

> **NCT06071442** · PHASE1 · COMPLETED · sponsor: **Alexion Pharmaceuticals, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Vemircopan
- **DRUG:** Rosuvastatin
- **DRUG:** Metformin
- **DRUG:** Levonorgestrel / Ethinyl Estradiol
- **DRUG:** Carbamazepine

## Key facts

- **NCT ID:** NCT06071442
- **Lead sponsor:** Alexion Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-17
- **Primary completion:** 2024-04-12
- **Final completion:** 2024-04-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06071442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06071442, "Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06071442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*